Royal Bank of Canada’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,812
Closed -$6K 6334
2024
Q2
$6K Buy
+2,812
New +$6K ﹤0.01% 6081
2023
Q3
Sell
-186
Closed -$2K 6537
2023
Q2
$2K Sell
186
-456
-71% -$4.9K ﹤0.01% 6377
2023
Q1
$6K Sell
642
-1,109
-63% -$10.4K ﹤0.01% 6103
2022
Q4
$17K Buy
1,751
+1,692
+2,868% +$16.4K ﹤0.01% 5889
2022
Q3
$1K Buy
59
+32
+119% +$542 ﹤0.01% 6645
2022
Q2
$0 Buy
+27
New ﹤0.01% 6861